Methylenedioxymethoxyethylamphetamine

MDMEOET
Clinical data
Other names3,4-Methylenedioxy-N-methoxyethylamphetamine; MDMEOET; MDMEOETA; N-Methoxyethyl-MDA
Routes of
administration		Oral
ATC code
  • None
Pharmacokinetic data
Duration of actionUnknown
Identifiers
  • 1-(2H-1,3-benzodioxol-5-yl)-N-(2-methoxyethyl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H19NO3
Molar mass237.299 g·mol−1
3D model (JSmol)
  • CC(Cc1ccc2c(c1)OCO2)NCCOC
  • InChI=1S/C13H19NO3/c1-10(14-5-6-15-2)7-11-3-4-12-13(8-11)17-9-16-12/h3-4,8,10,14H,5-7,9H2,1-2H3 X markN
  • Key:LOZJEWOZOKSOKA-UHFFFAOYSA-N X markN
 X markNcheckY (what is this?)  (verify)

MDMEOET, also known as 3,4-methylenedioxy-N-methoxyethylamphetamine or as N-methoxyethyl-MDA, is a psychoactive drug of the phenethylamine, amphetamine, and MDxx families. It is the N-methoxyethyl derivative of MDA.

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDMEOET's dose as greater than 180 mg orally and its duration as unknown. It produced few or no effects at tested doses.

Chemistry

Synthesis

The chemical synthesis of MDMEOET has been described.

Society and culture

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.

See also

References

  1. 1 2 3 4 5 6 7 Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
  2. ↑ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.